Trial
NCT00652093
Lumbar Stenosis Outcomes Research II
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
Endo USA Inc., a Keenova Therapeutics Company
Condition
Lumbar Spinal Stenosis
Intervention
opana then darvocet then placebo
Why stopped
Removal of Darvocet from US market
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-25